1711 - 1720 of 8801 Results
Title
Year
-
RESTRICTEDTitle: Consensus for the measurement of the camptocormia angle in the standing patientJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 52Issue #:Start Page: 1End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.013Citation Count: 68
-
RESTRICTEDTitle: Evaluation of Protein Identification and Quantification by the diaPASEF Method on timsTOF SCPJournal Name: Journal of the American Society for Mass SpectrometryPublisher: American Chemical Society (ACS)Vol: 35Issue #: 6Start Page: 1253End Page: 1260Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/jasms.4c00067Citation Count: 3
-
RESTRICTEDTitle: TC-8831, a nicotinic acetylcholine receptor agonist, reduces l-DOPA-induced dyskinesia in the MPTP macaqueJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 73Issue #:Start Page: 337End Page: 347Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.06.005Citation Count: 39
-
OPENTitle: Parkinson’s progression prediction using machine learning and serum cytokinesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0086-4Best OA location URL: https://www.nature.com/articles/s41531-019-0086-4.pdfCitation Count: 98
-
RESTRICTEDTitle: Genetic characterization of a cohort with familial parkinsonism and cognitive-behavioral syndrome: A Next Generation Sequencing studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 82End Page: 90Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.024Citation Count: 2
-
OPENTitle: Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-025-00896-zBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-025-00896-zCitation Count: 0
-
OPENTitle: A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, RespectivelyJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 6Start Page: 1018End Page: 1018Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11061018Best OA location URL: https://www.mdpi.com/2073-4409/11/6/1018/pdf?version=1647518110Citation Count: 5
-
OPENTitle: Cyclic Alternating Pattern Dynamics in Individuals at Risk for Developing Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 98Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.27217Citation Count: 1
-
RESTRICTEDTitle: Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 3Start Page: 417End Page: 421Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26483Citation Count: 41
-
RESTRICTEDTitle: P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 8Issue #: 4S_Part_3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2012.05.296Citation Count: 0